Cardiopathic intervention.

As clinical studies of cardiac disorders continue to develop, the electrophysiological mechanisms of various heart disorders have been identified and their treatment methods and techniques have been continuously improved. As a result, there have been significant changes in treatment programmes for the disease, and intervention in treatment is a non-pharmacological treatment that is very common in clinical terms, with a marked widening of the types of heart disorders that can be treated or treated at root and of adaptive disorders.i. Cardiac pacemaker implant therapyThe first pacemaker implant in the world was implemented in 1958, and the physico-physiology of the pacemaker function is constantly being updated. For a considerable period of time, a pacemaker is considered to be functionally compatible with room synchronisation and frequency response needs as a physical pacer, although with further clinical research, the effect of this traditional concept of physiology in improving the patient ‘ s prognosis has been accelerated at the tip of the right-heart; and studies have found that the higher the rate of sharpening in the right-heart, the greater the risk that the patient ‘ s heart twitches and heart failure can occur, thus improving the patient ‘ s prognosis by reducing the sharpness of the right-heart. The effect on the patient ‘ s prognosis is mainly due to the non-synchronous electrical agitation in the heart room, which results in a non-synchronous contraction in the heart room. In addition to this, there is a growing focus on the impact of the pace of cardiac selectivity (including right room spacing, side of the Hizebe/Heidel Beam) on reducing the non-synchronous electrical agitation of the heart room. At the new stage, it is considered clinically that the pace of the heart of the traditional right-heart is the main cause of the patient ‘ s fratricosis and heart failure, so that if the patient suffers from chronic heart disorder, he or she needs to be informed of his or her own conduction to the maximum extent possible during the application of a pacemaker implant for the patient ‘ s treatment, to avoid the creation of a non-synchronous electrical agitation and to minimize unnecessary right-heart agitation.II. Conduit digestion treatmentThe most rapid progress in research in the area of heart-ticking interventions is in the use of catheters to treat cardiac tremors, although over time there has been a tendency to reduce the proportion of digestive patients who maintain moist. In the case of patients with cardiovascular diseases, genetic cardiac disorders or instrumental heart disease combined with room tremors and cardiac hyperactivity are an important cause of heart arrest, while in recent years, as clinical medical techniques have improved and experience has increased, cathetic digestive treatment has had the most desirable therapeutic effect in the case of Brugada syndrome, cardiac arrhythmia, and post-cardial myocardial infarction, which can effectively reduce the risk of cardiac tremors and perturbations.III. ICD implantation treatmentAt this stage, there are more than half a million cases of heart attack per year in our country, posing a serious threat to the lives and safety of people. So far, there has been no effective anti-cardiological disorders that can effectively prevent heart sudden death, and ICD implant treatment is the only means of preventing the disease. The prevention of cardiac death can be divided into primary and secondary prevention, which is aimed at patients who have not had a heart stop but who are at high risk of dying; secondary prevention is directed at patients who have had a heart stop and have been rescued successfully. ICD implant treatment is an important medium for the second stage of heart arrest prevention. However, the fact that up to 95 per cent of patients with cardiac arrest outside the hospital have lost their lives before reaching the hospital and that only a small proportion of patients with cardiac arrest have the possibility of a secondary preventive measure is important.Traditional ICD implants are mainly implanted in the heart by an intravenous route, with patients at certain risk of complications such as endocardial infections, and more difficult to remove or replace electrodes at a later stage. The ICD (S-ICD) under the whole skin has been applied clinically in recent years, enabling it to be located through anatomically, without an X-ray, without complications due to basic operations, without contact with the heart, without an endocardial infection, and without guidance removal or replacement at a later stage. However, S-ICD has not been able to undergo pacemaker treatment for long periods of time after discharge, and S-ICD has not had the desired effect for a <170 frequency/minute of hypercardiology, and therefore there is a need for further research and continuous improvement of S-ICD implantation techniques.Concluding remarksIn sum, advances in science and technology have opened up new opportunities for research into and cure of the disease of heart disorders, and as medical technologies and medical devices continue to be developed, improved and optimized, case treatment experience has accumulated and analysed, confident that human research into and treatment of the various persistent heart disorders can achieve the desired results, albeit with hard journeys, but will eventually succeed.